Concepedia

David Rowe

DR

Statistics

Publications

7

Citations

3.8K

H-Index

7

Active since

2010

Affiliations

The University of Melbourne(Current)

University of Edinburgh

Peter MacCallum Cancer Centre

Memphis VA Medical Center

University of Cape Town

David Rowe is an author at The University of Melbourne specializing in medicine, placebo-controlled efficacy assessment, and hearing impairment.

ORCID

Publications per year

2010–2021

7

Publications

7

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

Delayed low frequency hearing loss caused by cochlear implantation interventions via the round window but not cochleostomy

David Rowe, Scott Chambers, Amy Hampson et al. · Hearing Research · 2015 · 29 citations

, , +16

Does surgical decompression in Ludwig's angina decrease hospital length of stay?

David Rowe, Jacob Ollapallil · ANZ Journal of Surgery · 2010 · 16 citations

, , +17

Impact of histological Oral Tongue Cancer margins on locoregional recurrence: A multi-centre retrospective analysis

James Daniell, Cristian Udovicich, David Rowe et al. · Oral Oncology · 2020 · 15 citations

, , +16

1–5 of 7